Thomas Isiah III 4
4 · One World Pharma, Inc. · Filed May 17, 2021
Insider Transaction Report
Form 4
Thomas Isiah III
DirectorCEO and Chairman
Transactions
- Award
Series B Preferred Stock
2021-05-17$15.00/sh+33,334$500,010→ 133,334 total(indirect: See Footnote)Exercise: $0.15From: 2021-05-17→ Common Stock (3,333,400 underlying)
Footnotes (2)
- [F1]The Series B Preferred Stock does not have an expiration date.
- [F2]The securities were purchased by ISIAH International LLC. The reporting person owns all of the membership interests in ISIAH International LLC, and is its Chairman and Chief Executive Officer.